Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Jekunen

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Antisense & Nucleic Acid Drug Development|January 1, 1996
Dosimetry of radionuclide therapy using radiophosphonated antisense oligodeoxynucleotide phosphorothioates based on animal pharmacokinetic and tissue distribution dataK J Kairemo, M Tenhunen, A P Jekunen
Anticancer Research|November 1, 1996
Modulation of antibody kinetics by the cell membrane active agent tween 80 in vivoK A Kairemo, P Karnani, A P Jekunen
Anti-Cancer Drug Design|September 1, 1996
Oligoradionuclidetherapy using radiolabelled antisense oligodeoxynucleotide phosphorothioatesK J Kairemo, M Tenhunen, A P Jekunen
Cancer Gene Therapy|January 23, 1999
Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclidesK J Kairemo, M Tenhunen, A P Jekunen
Clinical Nuclear Medicine|November 18, 1997
Imaging of Hand-Schüller-Christian syndrome by a monoclonal antibodyA P Jekunen, K J Kairemo, T Paavonen
The Journal of Laryngology and Otology|December 1, 1996
Somatostatin receptor imaging of olfactory neuroblastomaH A Ramsay, K J Kairemo, A P Jekunen
Bioanalysis|November 19, 2010
Microdosing in early lead discoveryA P Jekunen, E K J Pauwels, K J A Kairemo
American Journal of Clinical Oncology|August 1, 1996
Treatment of olfactory neuroblastoma. A report of 11 casesA P Jekunen, K J Kairemo, H P Lehtonen, et al.
Cancer|April 13, 2000
High response rate with a lower dose of paclitaxel in combination with cisplatin in heavily pretreated patients with advanced breast carcinomaA G Maiche, A P Jekunen, J Kaleva-Kerola, et al.
British Journal of Cancer|February 1, 1994
Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitroA P Jekunen, R D Christen, D R Shalinsky, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Antisense & Nucleic Acid Drug Development|January 1, 1996
Dosimetry of radionuclide therapy using radiophosphonated antisense oligodeoxynucleotide phosphorothioates based on animal pharmacokinetic and tissue distribution dataK J Kairemo, M Tenhunen, A P Jekunen
Anticancer Research|November 1, 1996
Modulation of antibody kinetics by the cell membrane active agent tween 80 in vivoK A Kairemo, P Karnani, A P Jekunen
Anti-Cancer Drug Design|September 1, 1996
Oligoradionuclidetherapy using radiolabelled antisense oligodeoxynucleotide phosphorothioatesK J Kairemo, M Tenhunen, A P Jekunen
Cancer Gene Therapy|January 23, 1999
Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclidesK J Kairemo, M Tenhunen, A P Jekunen
Clinical Nuclear Medicine|November 18, 1997
Imaging of Hand-Schüller-Christian syndrome by a monoclonal antibodyA P Jekunen, K J Kairemo, T Paavonen
The Journal of Laryngology and Otology|December 1, 1996
Somatostatin receptor imaging of olfactory neuroblastomaH A Ramsay, K J Kairemo, A P Jekunen
Bioanalysis|November 19, 2010
Microdosing in early lead discoveryA P Jekunen, E K J Pauwels, K J A Kairemo
American Journal of Clinical Oncology|August 1, 1996
Treatment of olfactory neuroblastoma. A report of 11 casesA P Jekunen, K J Kairemo, H P Lehtonen, et al.
Cancer|April 13, 2000
High response rate with a lower dose of paclitaxel in combination with cisplatin in heavily pretreated patients with advanced breast carcinomaA G Maiche, A P Jekunen, J Kaleva-Kerola, et al.
British Journal of Cancer|February 1, 1994
Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitroA P Jekunen, R D Christen, D R Shalinsky, et al.
Pageof 3